Retinitis

disease
On this page

Also known as inflammation of retinaretina inflammation

Summary

Retinitis (MONDO:0002708) is a disease (an umbrella term covering 5 Mondo subtypes) and 6 clinical trials. A subtype of retinal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 5 Mondo subtypes
  • Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameretinitis
Mondo IDMONDO:0002708
MeSHD012173
DOIDDOID:3612
NCITC115993
SNOMED CT399463004
UMLSC0035333
MedGen19765
GARD0023219
Is cancer (heuristic)no

Also known as: inflammation of retina · retina inflammation

Disease family

This is a subtype of retinal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorderretinal disorderretinitis

Related subtypes (31): retinal ischemia, rubeosis iridis, retinal vascular disorder, retinal nerve fiber layer disorder, retinal edema, retinal degeneration, night blindness, hypertensive retinopathy, macular holes, retinal detachment, iris hypoplasia with glaucoma, angioid streaks, bradyopsia, myopic macular degeneration, osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome, congenital retinal arteriovenous communication, Eales disease, central serous chorioretinopathy, achromatopsia, cancer-associated retinopathy, persistent placoid maculopathy, inherited vitreoretinopathy, retina neoplasm, retinal ciliopathy, melanoma associated retinopathy, isolated foveal hypoplasia, acute macular neuroretinopathy, autoimmune retinopathy, proliferative vitreoretinopathy, isolated chorioretinal dystrophy, torpedo maculopathy

Subtypes (5): cytomegalovirus retinitis, histoplasmosis retinitis, acute retinal necrosis syndrome, optic papillitis, retinal vasculitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3
PHASE1/PHASE21
PHASE21
PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04123626PHASE1/PHASE2ACTIVE_NOT_RECRUITINGA Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
NCT04945772PHASE2COMPLETEDEfficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
NCT00550498PHASE1TERMINATEDStem Cell Transplantation in Ocular Lesions of Behcet’s Disease
NCT06162585Not specifiedACTIVE_NOT_RECRUITINGNon-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
NCT00001734Not specifiedCOMPLETEDScreening for NEI Clinical Studies
NCT03753893Not specifiedCOMPLETEDOcular Manifestations in Rheumatic Diseases

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.